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Objective: To investigate glycemic dynamics and its relation 
with mortality in critically ill patients. We searched for differences 
in complexity of the glycemic profile between survivors and 
nonsurvivors in patients admitted to a multidisciplinary intensive 
care unit. 
Design: Prospective, observational study, convenience sample. 
Settings: Multidisciplinary  intensive  care  unit  of  a teaching 
hospital in Madrid, Spain. 
Patients: A convenience sample of 42 patients, aged 29 to 86 
yrs, admitted to an intensive care unit with an Acute Physiology 
and  Chronic  Health  Evaluation  II score  of  >14  and  with an 
anticipated intensive care unit stay of >72 hrs. 
Interventions: A continuous glucose monitoring system was 
used to measure subcutaneous interstitial fluid glucose levels 
every 5 mins for 48 hrs during the first days of intensive care unit 
stay. A 24-hr  period (n = 288 measurements) was used as time 
series for complexity analysis of the glycemic profile. 
Measurements: Complexity of the glycemic profile was evalu- 
ated by means of detrended fluctuation analysis. Other conven- 
tional measurements of variability (range, SD, and Mean Amplitude 
of Glycemic Excursions) were also calculated. 
Main  Results: Ten patients died during their intensive care 
unit  stay.  Glycemic  profile  was significantly  more  complex 
(lower detrended fluctuation analysis) in survivors (mean de- 
trended  fluctuation  analysis,  1.49;  95% confidence  interval, 
1.44 –1.53) than in nonsurvivors (1.60; 95% confidence interval, 
1.52–1.68).  This difference persisted after accounting for the 
presence of diabetes. In a logistic regression model, the odds 
ratio  for  death  was 2.18 for  every  0.1 change  in  detrended 
fluctuation analysis. 
Age,   gender,   Simplified   Acute   Physiologic   Score   3  or 
Acute  Physiologic  and  Chronic  Health  Evaluation  II scores 
failed to explain differences in survivorship. Conventional vari- 
ability  measurements  did  not  differ between  survivors  and 
nonsurvivors. 
Conclusions: Complexity of the glycemic profile of critically ill 
patients varies significantly between survivors and nonsurvivors. 
Loss of  complexity  in  glycemia  time series,  evaluated  by  de- 
trended fluctuation analysis, is associated with higher mortality. 
(Crit Care Med 2010; 38:849 – 854) 
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n recent years, there has been a 
growing interest in hyperglycemia 
associated with critical illness. 
Hyperglycemia in critically ill pa- 
tients is a consequence of several factors, 
including increased cortisol, cat- 
echolamines, glucagon, growth hor- 
mone, gluconeogenesis, and glycogenol- 
ysis (1, 2). In addition, insulin resistance 
has been demonstrated  in >80% of crit- 
ically ill patients (3). 
There is a wealth of observational 
evidence from  different,  mainly  surgi- 
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cal, patient populations demonst- 
rating  that  hyperglycemia is associated 
with poor clinical outcomes in critically 
ill patients (4 – 6). An important  limita- 
tion  in  such  observational  evidence is 
that it cannot prove that hyperglycemia 
causes poor clinical outcomes; hyper- 
glycemia may merely be a marker of 
severe illness. 
There is evidence from some ran- 
domized trials that correction and pre- 
vention of hyperglycemia improve mor- 
bidity and may also decrease mortality 
in some critically ill patients (7, 8). This 
suggests that there is a causal relation- 
ship between hyperglycemia and poor 
outcomes. Nevertheless, the optimal 
target  blood  glucose  is  controversial, 
and a widely accepted insulin  regimen 
has not been established. Furthermore, 
other  intervention  studies have yielded 
contradictory  results  (9). 
In recent  studies, variability in blood 
glucose levels has emerged as a new pre- 
dictor of mortality in intensive care unit 
 
(ICU) patients (10, 11). In the retrospec- 
tive studies by Egi et al (10) and Krinsley 
(11), the glycemic variability was ex- 
pressed as the SD of each patient’s blood 
glucose levels extracted from electroni- 
cally stored biochemical databases. The 
authors  proposed that  glycemic variabil- 
ity should be added as a metric to analyze 
ongoing and future clinical trials on in- 
tensive insulin therapy. 
We hypothesized that new techniques 
derived from nonlinear dynamics and 
fractal geometry could offer a more in- 
depth view of the glucoregulatory process 
than  the classic glucose variability mea- 
sures (SD or Mean Amplitude of Glycemic 
Excursions)  (12), therefore  allowing for 
the  detection  of slighter  changes  argu- 
ably correlated with the patient’s physio- 
logic status. 
Nonlineal dynamics (the study of the 
behavior of nonlineal deterministic  sys- 
tems) is increasingly been used in phys- 
iologic studies. Nonlineal systems dis- 
play an extremely complex output  that, 
 
 
   
although being rigorously determinis- 
tic, is unpredictable  and, at first glance, 
seems to be random (thus, the term 
“pseudorandom”). These systems have 
some striking similarities with certain 
physiologic mechanisms: They exhibit a 
The aim of this pilot study was to 
investigate the complexity of the glyce- 
mic profile in critically ill patients. 
Namely, we searched for differences in 
complexity of glycemic profile  between 
the patients who survive and the patients 
Table 1.   Characteristics  of patients  included in 
the study 
 
Characteristic  n = 38 
 
Age, yrs (range)  59 (29–86) 
Sex, male/female  25/13 
pseudorandom  behavior,  they  tend  to 
develop  spontaneous   rhythms,   and 
who die in the ICU. We hypothesized that 
the glycemic profile would be less com- 
Median APACHE II score at first 
24 hrs (IQR) 
19 (16–22) 
most notably, they have a strong ten- 
dency to remain in a narrow range of 
values (“strange attractors”), displaying 
a behavior that could easily be called 
homeostatic. 
Complexity  analysis  of  time  series 
has been widely used in the study of 
variability of biological phenomena, 
such as cardiac interbeat interval (13), 
cardiac  arrhythmia   (14,  15),  intracra- 
nial hypertension (16), sepsis and organ 
failure  (17,  18),  temperature   (19,  20) 
and  electroencephalogram   activity  (21, 
22). Ogata et al (23) and Churruca  et al 
plex in nonsurvivors. 
MATERIALS AND METHODS 
Patients 
 
A convenience sample of 42 successive pa- 
tients  who were admitted  to the  ICU of 
Mostoles Hospital in Madrid, Spain, from No- 
vember 2007 to January 2009, participated in 
the study. We included in our study patients 
aged Š18  yrs, with an Acute Physiology and 
Chronic Health Evaluation (APACHE) II score 
of Š14,  and with an anticipated  ICU stay of 
Mean SAPS 3 score (SD) 61 (12) 
Mean length of stay, days (SD) 23 (21) 
History of DM type 2, n (%) 11 (29) 
Treated with insulin, n 3 
Treated with oral antidiabetic  8 
agent, diet or both, n 
Reason for intensive care, n 
Acute respiratory failure 21 
Gastrointestinal  bleeding 4 
Myocardial infarction  4 
Heart failure 2 
Cerebral infarction  2 
Peritonitis  2 
Pancreatitis  1 
Acute renal failure 1 
Trauma  1 
Glucose at admission, mg/dL (SD) 165 (80) 
(24) have analyzed diabetes-related alter- 
ations of glucose control by means of 
complexity analysis of the glycemic pro- 
file. They have reported diminished com- 
>72 hrs. 
Collected demographic data included 
age,  comorbilities,   and  reason   for  inte- 
nsive  care.  We  also  recorded  APACHE II 
Location from which the patient 
was admitted to the ICU 
ward/emergency room/other 
ICU 
12/23/3 
plexity of glycemic profile in diabetic pa- 
tients vs. healthy volunteers. Several 
authors have proposed that critical illness 
and multisystem organ dysfunction are 
characterized  by the phenomenon  of de- 
complexification (25). Healthy state ex- 
hibits some degree of (pseudo)random 
variability in physiologic variables, 
such as heart rate or temperature. Loss 
of such irregularity (and consequently of 
complexity) is one of the  hallmarks  of 
critical illness (26, 27). 
It  should  be noted  that  complexity 
and variability, although  seemingly re- 
lated, are quite different and often con- 
tradictory concepts. A key difference be- 
tween variability and complexity 
metrics is that, although  variability is 
based on conventional statistics (range, 
SD) and, thus,  takes each measurement 
as an independent  value, in complexity 
analysis, each measure is related to its 
neighbors. This arguably allows com- 
plexity  analysis  to  detect  minor   sys- 
temic dysfunctions, not perceived by 
variability studies. In general, a healthy 
regulatory system displays a complex 
output, with frequent and quick correc- 
tions of even small deviations. On the 
other  hand, a failing regulatory  system 
will be sluggish and allow for greater 
deviations  before  reacting.  Therefore, 
as  a  rule  of  thumb,   healthy  systems 
have a high complexity and low vari- 
ability, while failing systems display 
lower complexity and higher variability. 
score  during   the  first  24  hrs,  Simplified 
Acute Physiologic Score (SAPS) 3 score, 
blood glucose, and basic hematologic and 
biochemical parameters  at the time of ad- 
mission.  Type of nutrition, units  of insulin 
administered,  and use of vasoactive drugs 
during the registry were also recorded. A 
patient was considered to have diabetes if 
he/she  had been informed  of this  diagnosis 
and received treatment (diet, tablets, or in- 
sulin).  For  the  final analysis, we classified 
the patients as either survivors (those who 
were finally discharged  from the  ICU) or 
nonsurvivors (patients who died in the ICU). 
Table 1 summarizes  the main clinical data. 
The study was approved by the institu- 
tional ethics committee  at Mostoles Hospital 
(Madrid, Spain), and all subjects, or their legal 
surrogate, gave their informed consent to par- 
ticipate. 
 
Glycemia Measurements 
 
A continuous  glucose monitoring  system 
(CGMS) (CGMS System  Gold, Medtronic 
MiniMed, Northridge, CA) was used to mon- 
itor subcutaneous  interstitial fluid glucose 
levels (28, 29). The patients had a sensor 
inserted in the abdominal subcutaneous  tis- 
sue, and interstitial  glucose was recorded 
every 5 mins for at least 48 hrs  during  the 
first days of their  ICU stay. In two patients, 
for technical  reasons,  the  glycemic record- 
ing was not performed until  the second and 
third  week. Four finger-stick blood glucose 
measurements  were introduced to the 
Medtronic MiniMed daily to calibrate  the 
measurements.   Otherwise,  the  patients  re- 
Mortality, n (%)                                    10 (26) 
 
APACHE, Acute  Physiology  and  Chronic 
Health Evaluation; IQR, interquartile  range; 
SAPS, Simplified  Acute Physiology Score;  DM, 
diabetes mellitus; ICU, intensive care unit. 
 
 
ceived  standard   care,  including   nutrition 
and insulin therapy, according to their at- 
tending physician. A glucose time series was 
obtained from each subject and downloaded 
to a computer.  We then  extracted  a 24-hr- 
long series for study, from 8 AM  on day 2 to 
8 AM  on day 3 (in seven patients, the data set 
did not start at 8 AM  because of technical 
problems,  but  in  every case, there  were at 
least 8 hrs of run-in  period before the ana- 
lyzed data set). 
Conventional statistics (mean or median, 
SD, and Mean Amplitude of Glycemic Excur- 
sions) were calculated from each time 
series. 
 
Complexity Analysis 
 
Complexity was assessed through  de- 
trended  fluctuation  analysis  (DFA). An in- 
depth discussion on DFA is beyond the scope 
of this paper and can be consulted elsewhere 
(30). Nonetheless, we provide a succinct de- 
scription  of the  analytical procedure  in the 
Appendix. DFA is a unitless  metric  that  es- 
timates  the  degree  of  long-range  correla- 
tions within a signal analyzing how the time 
series  and  its  linear  regression  diverge  as 
the “time window” considered increases. In- 
tuitively,  DFA can  be  conceived  as  repre- 
senting the span of influence of the different 
 
 
   
Sex, male/female 
Age, yrs (95% CI) 
17/11 
57 (52–63) 
8/2 
62 (50–73) 
.44 (NS) 
.42 (NS)b 
History of diabetes mellitus type 2, n (% of patients) 10 (36) 1 (10) .22 (NS)a 
APACHE II score at first 24 hrs (95% CI) 21 (19–23) 19 (15–22) .30 (NS)b 
SAPS 3 score (95% CI) 60 (55–64) 65 (57–73) .27 (NS)b 
PCR (95% CI) 117 (77–157) 106 (39–174) .79 (NS)b 
Glucose at admission, mg/dL (95% CI) 
Daily insulin during the registry 
n (% of patients) 
178 (148–208) 
 
17 (61) 
129 (79–179) 
 
7 (70) 
.095 (NS)b 
Mean dose, IU 35 36  
 
points in a time series. In a series with high 
complexity, the influence of each point rap- 
idly fades away, whereas in a “smoother” 
series, the influence of each point lasts 
longer. As a rule of thumb,  higher complex- 
ities  are  displayed  as  lower  DFA (until  a 
minimum  of 0.5). 
 
Statistical Analyses 
 
The complexity of the glycemic profile, 
measured  as DFA, followed a normal  distri- 
bution   as  confirmed   by  a  Kolmogorov- 
Table 2.  Differences between survivors and nonsurvivors  
 
Survivors 
n = 28 
 
 
Nonsurvivors 
n = 10 p 
 
a 
Smirnov  test.  Differences in  DFA between 
survivors and nonsurvivors were evaluated 
using analysis of variance. A predictive 
model of the final outcome based on com- 
plexity and clinical variables was built 
through  logistic regression. 
All analyses were performed  with  SPSS 
software  version  12  (SPSS,  Inc.,  Chicago, 
IL), and p < .05 was considered to be 
statistically significant. Results are re- 
ported as mean values and 95% confidence 
interval (CI). 
RESULTS 
Patients 
Of the  42  patients  enrolled  in  the 
study, four patients were excluded be- 
cause of failure of the glucose monitoring 
system; all four were survivors. Except for 
a slightly higher  mean APACHE II score 
(28 vs. 20), the missing patients were 
similar (regarding gender, age, glucose at 
admission, and SAPS III score) to those 
reported. 
A  total of 28 (74%) patients  survived 
Median glucose during the registry, mg/dL (95% CI)    138 (124–151)      144 (122–167)       .60 (NS)b 
SD of glucose during the registry, mg/dL (95% CI)         17 (13–20)            22 (16–29)           .13 (NS)b 
MAGE (95% CI)                                                                   41 (30–51)            34 (17–51)             .5 (NS)b 
DFA (95% CI)                                                                   1.49 (1.44–1.53)   1.60 (1.52–1.68)       .015b 
 
CI, confidence interval; APACHE, Acute Physiology and Chronic Health Evaluation; SAPS, Sim- 
plified Acute Physiology Score; PCR, polymerase chain reaction; MAGE, Mean Amplitude of Glycemic 
Excursions; DFA, detrended fluctuation  analysis. 
aFisher’s exact test; banalysis of variance. The p values refer to the differences between the groups. 
 
 
 
Figure 1. Examples of glycemic profile. Two examples of glycemic curves, from a survivor (A) and a 
nonsurvivor (B). Although the glycemic values are not significantly different (average glycemia, 119 
mg/dL in A; 128 mg/dL in B), the complexity of the survivor’s profile A is greater  (lower detrended 
fluctuation  analysis [DFA]) than that of the nonsurvivor. 
 
 
a  surviving  and  a  nonsurviving  patient 
and ten (26%) died in the ICU. One pa- 
tient  died in the internal  medicine ward 
16 days after being discharged from the 
ICU (and, hence, was considered a survi- 
vor in our analyses). The rest of the ICU 
survivors were discharged home after 
their hospital stay. There were no signif- 
icant differences between survivors and 
nonsurvivors in age, APACHE II, or SAPS 
3 scores (Table 2). Glycemia at the time 
of admission was higher in survivors than 
in  nonsurvivors,   although   it  did  not 
reach   statistical   significance  (mean, 
178 mg/dL; 95% CI, 148 –208 in survi- 
vors vs. 129 mg/dL; 95% CI, 79 –179 in 
nonsurvivors,  p = .095). Neither mean 
glucose, its SD, or Mean Amplitude of 
Glycemic  Excursions  during  the  glu- 
cose recording differed between survi- 
vors and nonsurvivors. 
Table 2 summarizes  the main patient 
characteristics in each group. Represen- 
tative examples of glycemic profiles from 
are shown in Figure 1. 
 
Complexity Analysis 
 
DFA was significantly lower (indicat- 
ing higher complexity) in surviving pa- 
tients than in patients dying in the ICU 
(1.49 [95% CI, 1.44 –1.53] vs. 1.60 [95% 
CI,  1.52–1.68],  F(1,36)  = 6.548,  p  = 
.015). This difference persisted even after 
inclusion of the presence of diabetes, age, 
APACHE II,  and  SAPS 3  score  in  the 
model (F(1,31) = 12.581, p = .001). 
DFA did not  differ according to gen- 
der, and did not correlate with age, 
APACHE II, or SAPS 3 scores. We found 
no significant differences in DFA in relation 
to type of feeding (oral, enteral, or paren- 
teral) or in relation to the amount of insu- 
lin administered during the registry. 
There was a positive significant corre- 
lation between DFA and both mean glu- 
cose (r = .339, p = .046) and glucose SD 
(Spearman’s g = 0.457, p = .006) during 
the testing day. There was no correlation 
between Mean Amplitude of Glycemic Ex- 
cursions  and DFA. 
DFA was not  different  between  dia- 
betic and  nondiabetic  patients  (1.51 vs. 
1.52, p = .92). However, survival acted as 
a confounding factor, and when control- 
ling for this variable, the DFA estimated 
marginal  mean for diabetic patients  was 
1.67 (95% CI, 1.60 –1.79) vs. 1.54 (95% 
CI,  1.49 –1.59)  in  nondiabetic  patients 
(p = .039 for diabetes, p = .001 for sur- 
vival, p = .025 for the interaction  diabe- 
tes × survival). 
In  a  logistic  regression  model,  DFA 
was significantly associated with mortal- 
ity (—2LLR, 37.729, p = .028). The odds 
ratio for death associated with a 0.1 in- 
crease in DFA was 2.18 (95% CI, 1.09 – 
4.37). These results did not change sig- 
nificantly after controlling for the 
presence of diabetes (—2LLR, 33.984, p = 
 
 
   
.019;  odds  ratio,  2.53;  95%  CI,  1.16 – 
5.49). 
 
DISCUSSION 
 
Our data show a significant differ- 
ence in the complexity of the glycemic 
profile between nonsurvivors and survi- 
vors in a multidisciplinary  ICU patient 
population. Loss of complexity in the 
glycemic profile is accompanied by a 
higher odds ratio of death, and the size 
of this effect is not negligible: a 0.1 
increase  in  DFA roughly  doubles  the 
odds of death for the patient. 
An unexpected finding was the lack of 
differences in DFA between diabetic and 
nondiabetic patients, because other stud- 
ies (23, 24) have consistently found an 
increased DFA in diabetes. However, our 
results are probably due to confounding 
factors. The odds of survival were para- 
doxically increased in diabetic patients 
(10:1 vs. 18:9), and when this variable was 
controlled, a clear difference in estimated 
marginal means appeared. 
Dynamic measures  of glucose time se- 
ries seem to provide complementary—and 
perhaps more powerful—information on 
glucoregulation  than  conventional  glyce- 
mic analysis. These measurements  differ 
from traditional variability measure- 
ments  because they are not  related  to 
the magnitude  of variability, but rather 
to  its  organization.  Our  hypothesis  is 
that a healthy regulatory system is able 
to detect small changes in glucose con- 
centration  and makes continuous  small 
adjustments.  Even minor changes in 
glucose concentration might launch 
prompt counterregulatory measures to 
adjust the glucose concentration.  Thus, 
the tracing of glucose concentration 
would be characterized  by frequent 
small ups-and-downs displaying high 
complexity (low DFA) and low variabil- 
ity (low SD). A failing regulatory system 
may require  bigger changes in glucose 
concentration to launch a counterregu- 
latory response. In this case, the tracing 
of glucose concentration would show 
low  complexity  (high  DFA) and  high 
variability (high  SD). As expected, our 
sample displayed an inverse correlation 
between complexity and variability (di- 
rect correlation  between DFA and SD of 
the  glycemic  tracing:  Spearman’s  g  =   
0.457, p = .006). 
It has been suggested that scale invari- 
ance may be a central organizing princi- 
ple of physiologic structure and function. 
The  diminished   complexity  (i.e.,  in- 
creased  DFA) of the  glucose  profile  in 
nonsurvivors  suggests  a  breakdown  of 
this scale invariant,  fractal organization, 
and, thus, a failing glucoregulatory sys- 
tem,  even  before  the  development  of 
overt hyperglycemia. 
To our knowledge, this is the first at- 
tempt  to quantify the complexity of glu- 
cose profile in critically ill patients. Ogata 
et al (23, 31) analyzed diabetes-related 
alterations of glucose control by means of 
DFA by use of a CSMG, reporting  a mean 
DFA 1.25 ! 0.29 in healthy volunteers. 
All of the  critically  ill  patients  in  our 
series had DFA values greater than those 
reported by Ogata et al (23, 31), which 
supports our hypothesis that critical ill- 
ness and multisystem organ dysfunction 
are characterized  by a loss of complexity 
in the glycemic profile. 
An obvious limitation  of our study is 
that  the  accuracy of point-of-care  blood 
glucose  testing  in  critically  ill  patients 
has proven to be poor (32, 33). Our mea- 
surements are based on a subcutaneous 
CGMS. Corstjens et al (34) have studied 
the accuracy of this method  in critically 
ill patients, and their results show a Pear- 
son correlation coefficient of 0.89 for 
CGMS vs.  blood  gas  analyzer.  On  the 
other hand, it is worth noting that an 
advantage of dynamic methods is that, 
rather than aiming at the specific value of 
each  measure,  they  focus on  how each 
measure relates with previous and suc- 
cessive ones. They are more interested in 
variation than  in values, and this makes 
them   more  robust  against  systematic 
bias. 
Our recruiting  rhythm was admittedly 
slow. We had to share the CGMS device 
with the  Departments  of Endocrinology 
and Pediatrics and, naturally, patient car- 
ing was a priority. Thus, the studied pa- 
tients constituted  a convenience sample, 
not a consecutive series of patients ad- 
mitted  to the  ICU, and we could not 
maintain  standardized timing of com- 
plexity measurements.  In all patients, the 
glycemic profile was obtained during 
their first week of ICU stay (four patients 
on day 1; 15 patients on day 2; 11 patients 
on day 3; two patients on day 4; four 
patients on day 5; and two patients on day 
6). In two cases, the initial continuous 
glucose series failed, and had to be re- 
peated.  For  technical  reasons,  this  was 
not possible until weeks 2 and 3, respec- 
tively. Both patients  were survivors. The 
exclusion of these cases from the analysis 
did not change the results (i.e., DFA sur- 
vivors,  1.48;  nonsurvivors,   1.60;  p  = 
.018) . 
Another limitation of our study is that 
patients were not following a standard- 
ized protocol for feeding, infusions, and 
insulin administration. Nevertheless, in 
acutely ill patients admitted to an ICU, 
these types of rigid protocols are probably 
not  feasible, and we were willing to re- 
flect a real-life situation. 
As for  the  mechanisms   underlying 
this loss of complexity, one can only 
speculate. A seductive explanation 
could be based on the “uncoupling” of- 
ten observed in failing complex sys- 
tems. Another obvious candidate is in- 
sulin   resistance    i n   a   context   o f 
increased counterregulatory hormones. 
A more unlikely and less physiologically 
attractive (but perhaps more clinically 
useful)  hypothesis  would  assume  that 
the impaired complexity in the intersti- 
tial fluid only represents a poor hemo- 
dynamic status, with peripheral hy- 
poperfussion and delayed equilibrium. 
As in previous studies,  we do not 
establish whether glycemic dysregula- 
tion  is the  cause of an impaired  prog- 
nosis or whether it is just a marker of 
physiologic breakdown. However, our 
results  indicate  that  complexity analy- 
sis  may  constitute   a  powerful  tool  in 
the study of glycemic control in critical 
care patients. 
 
 
CONCLUSIONS 
 
In critically ill patients, there is a 
difference in the complexity of the gly- 
cemic profile between survivors and 
nonsurvivors. Loss of complexity in gly- 
cemia time series, evaluated by DFA, 
correlates with higher mortality. Com- 
plexity analysis may offer new insights 
in issues involving glucose control in 
critically ill patients. 
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Appendix 
 
Detrended Fluctuation Analysis 
 
Detrended fluctuation analysis 
(DFA) attempts  to  disclose patterns  of 
self-similarity in time plots. In other 
words, it looks for the presence of 
“memory” in the curve, understood as 
long-range  correlations. 
To be able to perform DFA, it is first 
necessary to integrate  the time series: 
 
y(k) = k     (G — G )  
9.  NICE-SUGAR Study Investigators, Finfer S, 
 
tegr  Comp  Physiol  2006;  291:R1638 – 
i=1     i mean 
Chittock  DR, et  al: Intensive  versus  con- 
ventional  glucose  control  in  critically  ill 
patients.   N   Engl   J   Med   2009;   360: 
1283–1297 
10.  Egi M, Bellomo R, Stachowski E, et al: Vari- 
ability of blood glucose concentration and 
short-term  mortality in critically ill patients. 
Anesthesiology 2006; 105:244 –252 
11. Krinsley JS: Glycemic variability: A strong 
independent  predictor  of mortality  in criti- 
R1643 
24.  Churruca  J, Vigil L, Luna E, et al: The route 
to diabetes: Loss of complexity in the glyce- 
mic profile from health through the meta- 
bolic syndrome to type 2 diabetes. Diabetes, 
Metabolic  Syndrome   and  Obesity  2008; 
1:3–11 
25.  Goldstein  B, Fisher  DH, Kelly MM, et  al: 
Decomplexification in critical illness and in- 
jury: Relationship  between  heart  rate  vari- 
(Fig.  2A),  where  Gi   is  each  individual 
point, and Gmean  is the mean of the series 
as a whole. 
Next, the integrated  curve is divided 
into  time  segments  of  size  n  (Fig.  2, 
B–D). A regression  line is calculated for 
each segment, and the difference between 
the integrated curve and the different re- 
gression lines is computed as: 
cally ill patients.  Crit Care Med 2008; 36: 
3008 –3013 
12.  Service FJ, Molnar GD, Rosevear JW, et al: 
ability, severity of illness, and outcome. Crit 
Care Med 1998; 26:352–357 
26.  Kennedy HL: Heart  rate  variability—A po- F(n) = )1    [y(k) — yn(k)]2,  
Mean amplitude  of glycemic excursions,  a 
measure   of  diabetic  instability.  Diabetes 
1970; 19:644 – 655 
13.  Pikkuja¨ msa¨  SM, Ma¨ kikallio  TH, Sourander 
LB, et al: Cardiac interbeat interval dynamics 
from childhood  to senescence: Comparison 
of conventional and new measures based on 
fractals and chaos theory. Circulation 1999; 
100:393–399 
14.  Vikman S, Makikallio TH, Yli-Mayry S, et al: 
Altered complexity and correlation  proper- 
ties of R-R interval dynamics before the 
spontaneous onset of paroxysmal atrial fibril- 
lation. Circulation 1990; 100:2079 –2084 
15.  Makikallio TH, Seppanen T, Airaksinen KE, 
et al: Dynamic analysis of heart rate may 
predict subsequent ventricular tachycardia 
after  myocardial  infarction.  Am  J  Cardiol 
1997; 80:779 –783 
16.  Hornery R, Aboy M, Abasolo D, et al: Com- 
plexity analysis of intracranial  hypertension 
using  approximate  entropy.  Crit Care Med 
2006; 34:87–95 
17.  Toweill D, Sonnenthal  K, Kimberly B, et al: 
tential, non-invasive prognostic index in the 
critically ill patient. Crit Care Med 1998; 26: 
213–214 
27.  Seely AJ, Christou  NV: Multiple organ  dys- 
function  syndrome: exploring the  paradigm 
of complex nonlinear systems. Crit Care Med 
2000; 28:2193–2200 
28.  Rebrin K, Steil GM: Can interstitial  glucose 
assessment replace blood glucose measure- 
ments?   Diabetes   Technol   Ther   2000; 
2:461– 472 
29. Konschinsky T, Heinemann  L: Sensors for 
glucose monitoring: technical and clinical 
aspects. Diabetes Metab Res Rev 2001; 17: 
113–123 
30.  Peng CK, Havlin S, Stanley HE, et al: Quan- 
tification of scaling exponents and crossover 
phenomena in nonstationary heartbeat time 
series. Chaos 1995; 5:82– 87 
31. Ogata H, Tokuyama K, Nagasaka S, et al: 
Long-range  correlated  glucose  fluctuations 
in  diabetes.  Methods  Inf  Med  2007;  46: 
222–226 
32.  Louie RF, Tang Z, Sutton DV, et al: Point-of- 
care glucose testing:  Effects of critical care 
N 
k=1 
 
where F(n) is the area between the in- 
tegrated curve and the regression lines, 
N is the  total  number  of data  points, 
y(k) is the value of the integrated curve 
at each point, and yn(k) is the value of 
the regression  line at that  point. 
This operation is repeated for different 
time frames (that  is, for different values 
of n). The smaller the time scale (n), the 
better the fit of the regression lines to the 
integrated  curve and the lower the value 
of F(n). Conversely, the value of F(n) 
tends  to  increase  exponentially  as  the 
time frame (n) increases. 
Finally, the relation between F(n) and 
the size of n is analyzed. A plot is drawn 
with log[F(n)] on the y-axis and log(n) on 
the x-axis (Fig. 2E). A good fit to a regres- 
sion line indicates the existence of scaling 
(self-similarity),  and  a  fractal  structure 
can be assumed. 
 
 
   
k 
 
Figure 2.   Detrended fluctuation  analysis (DFA). From the original time series, an integrated  curve is obtained (A). 
 
y(k) = i=1(Gi  — Gmean), 
where Gi indicates each individual point; Gmean indicates mean of the series as a whole. This integrated curve will be utilized for further calculations. The integrated 
curve is divided into progressively smaller time segments (B, C, D). A regression line is calculated for each segment, and the total difference between the integrated 
curve and the regression lines is calculated for each time window (F(n), gray area). The smaller the time window, the better the fit of the regression line and the 
lower the value of F(n). Finally, a plot is drawn (E) with log (F(n) in the y-axis and log (time-window) in the x-axis. A good fit reveals the presence of scaling 
(self-similarity). DFA is the slope of the regression line. It displays the scaling exponent and is an indicator of the degree of complexity of the curve. 
 
 
DFA is  the  slope  of the  regression 
line (a). It displays the scaling expo- 
nent,  and is an indicator  of the degree 
of complexity of the curve. In an en- 
tirely random time series (“white 
noise”), a = 0.5. A 1/f type time series 
will have a = 1. A “random walk” (the 
integration  of a random  series, “brown 
noise”) will display a = 1.5. Long-range 
negatively correlated fluctuations will 
show a <1.5, whereas in positive cor- 
relations,  a >1.5. 
On the whole, a curve is more com- 
plex  (less  predictable)  the  closer  its 
value of a is to 0.5. (Values of a <0.5 
reveal  anticorrelations,  which  also 
implies a certain degree of predict- 
ability, and hence, a lower level of com- 
plexity). 
In our series, n = 288. 
The  program  used  to  calculate  DFA 
was written in Python (http://www. 
python.org) and is available from the au- 
thors on request. 
